Novacyt Achieves US FDA Emergency Use Authorization for COVID-19 Diagnostic Test
Novacyt, an international specialist in clinical diagnostics, is pleased to announce that the US Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its COVID-19 diagnostic test. As a result, hospitals and laboratories in the US will be able to use the test for clinical diagnosisRead